HU165172B - - Google Patents

Info

Publication number
HU165172B
HU165172B HUAI224A HUAI000224A HU165172B HU 165172 B HU165172 B HU 165172B HU AI224 A HUAI224 A HU AI224A HU AI000224 A HUAI000224 A HU AI000224A HU 165172 B HU165172 B HU 165172B
Authority
HU
Hungary
Application number
HUAI224A
Other languages
Hungarian (hu)
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of HU165172B publication Critical patent/HU165172B/hu

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D231/00Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/54Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings condensed with carbocyclic rings or ring systems
    • C07D231/56Benzopyrazoles; Hydrogenated benzopyrazoles

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
HUAI224A 1972-02-29 1973-02-27 HU165172B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT48628/72A IT1052111B (it) 1972-02-29 1972-02-29 Acidi i benzil i h indazol 3 carbossilici sostituiti e loro derivati

Publications (1)

Publication Number Publication Date
HU165172B true HU165172B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) 1974-07-27

Family

ID=11267725

Family Applications (1)

Application Number Title Priority Date Filing Date
HUAI224A HU165172B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) 1972-02-29 1973-02-27

Country Status (9)

Country Link
US (1) US3895026A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
CA (1) CA994347A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
DE (1) DE2310031C3 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
FR (1) FR2181773B1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
GB (1) GB1381422A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
HU (1) HU165172B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
IN (1) IN139264B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
IT (1) IT1052111B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
NL (1) NL179729C (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1050741B (it) * 1975-12-01 1981-03-20 Acraf Utilizzazione degli acidi i benzil ih indazol 3 carbossilici sostituiti e loro derivati nel campo della contraccezione femminile
US5229408A (en) * 1988-07-15 1993-07-20 Ici Pharma 4-carbamoyl-1,2-dihydro-3H-indazol-3-one derivatives
US5914405A (en) * 1997-10-07 1999-06-22 Eli Lilly And Company Process for preparing 3-substituted indazoles
US6001865A (en) * 1999-05-04 1999-12-14 Angelini Pharmaceuticals Inc. 3-substituted 1-benzyl-1H-indazole derivatives as antifertility agents
KR100424341B1 (ko) * 2001-10-23 2004-03-24 하나제약 주식회사 1-메틸인다졸-3-카르복실산의 제조방법
US20060276527A1 (en) * 2003-01-17 2006-12-07 Thresold Pharmaceuticals, Inc. Combination therapies for the treatment of cancer
CA2513572A1 (en) * 2003-01-17 2004-08-05 Threshold Pharmaceuticals, Inc. Treatment of benign prostatic hyperplasia
ES2378071T3 (es) * 2004-03-24 2012-04-04 Janssen Pharmaceutica Nv Moduladores de cannabinoides de tetrahidro-indazol
WO2005120498A2 (en) * 2004-06-03 2005-12-22 Threshold Pharmaceuticals, Inc. Method for synthesis of lonidamine and related indazole derivatives
WO2006010077A2 (en) * 2004-07-08 2006-01-26 Threshold Pharmaceuticals, Inc. Prodrugs of lonidamine and lonidamine analogs
US7514463B2 (en) * 2004-08-20 2009-04-07 University Of Kansas Lonidamine analogues and their use in male contraception and cancer treatment
CN101759644B (zh) * 2005-08-17 2011-11-02 杭州民生药业有限公司 氯尼达明的结晶形式iii、其制备方法和含有所述结晶形式iii的组合物
CN101735151B (zh) * 2005-08-17 2012-07-04 杭州民生药业有限公司 氯尼达明的结晶形式i、其制备方法和含有所述结晶形式i的组合物
KR20120069658A (ko) * 2009-07-06 2012-06-28 유니버시티 오브 캔사스 생식력 제어를 위한 로니다민 유사체
WO2016201426A1 (en) 2015-06-12 2016-12-15 Vettore, LLC Mct4 inhibitors for treating disease
AU2017375960B2 (en) 2016-12-12 2022-03-10 Vettore, LLC Heterocyclic inhibitors of MCT4
JP2023541944A (ja) * 2020-09-17 2023-10-04 エサイエント ファーマシューティカルズ,インコーポレイティド Mas関連gタンパク質受容体x4のモジュレーター、並びに関連製品及び方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3007938A (en) * 1959-04-17 1961-11-07 Sterling Drug Inc 1-(3-indazolecarbonyl)-hydrazines and their preparation
US3145215A (en) * 1961-12-19 1964-08-18 Sterling Drug Inc Indazole derivatives
IL28032A (en) * 1966-08-29 1971-08-25 Acraf Indazol-3-yl-oxyalkanoic acids and process for the preparation thereof
US3567721A (en) * 1968-11-29 1971-03-02 Geigy Chem Corp Indazolecarboxylic acids and derivatives thereof
DE1948793A1 (de) * 1969-09-26 1971-04-01 Rhein Chemie Rheinau Gmbh Verfahren zur Herstellung von 4,5,6,7-Tetrahydroindazolen

Also Published As

Publication number Publication date
NL7302669A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) 1973-08-31
DE2310031B2 (de) 1979-11-15
NL179729B (nl) 1986-06-02
US3895026A (en) 1975-07-15
DE2310031C3 (de) 1980-07-31
GB1381422A (en) 1975-01-22
IN139264B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) 1976-05-29
FR2181773A1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) 1973-12-07
NL179729C (nl) 1986-11-03
CA994347A (en) 1976-08-03
FR2181773B1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) 1975-12-26
IT1052111B (it) 1981-06-20
DE2310031A1 (de) 1973-09-20

Similar Documents

Publication Publication Date Title
FR2193354A5 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
FR2181773B1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
FR2178892B1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
JPS4915866A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
JPS528664Y2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
JPS5443383B2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
JPS5512652B2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
JPS494496U (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
FR2197193A1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
JPS4922755U (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
FR2209739B1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
JPS4894416U (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
CS152726B1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
CH578143A5 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
CH564104A5 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
CH570453A5 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
CH570671A5 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
BG18459A1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
CH574892A5 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
CH570181A5 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
BG18226A1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
CH577505A5 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
BG18209A1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
CH570051A5 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
CH569190A5 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)

Legal Events

Date Code Title Description
HU90 Patent valid on 900628
HMM4 Cancellation of final prot. due to non-payment of fee